(Q46654894)

24 December 2017

title

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. (English)

1 reference

24 December 2017

author name string

Teitelbaum D

1

1 reference

24 December 2017

Meshorer A

2

1 reference

24 December 2017

Hirshfeld T

3

1 reference

24 December 2017

Arnon R

4

1 reference

24 December 2017

Sela M

5

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 August 1971

1 reference

24 December 2017

European Journal of Immunology

published in

1 reference

24 December 2017

volume

1

1 reference

24 December 2017

page(s)

242-248

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

Experimental allergic encephalomyelitis. Isolation of basic proteins and polypeptides from central nervous tissue.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

Basic proteins from the acidic extract of bovine spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Experimental allergic encephalomyelitis and autoimmune disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelin.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Basic encephalitogenic protein: A simplified purification on sulphoethyl-sephadex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Synthesis and chemical properties of poly-alpha-amino acids

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Synthesis, characterization, and acemization of poly-L-serine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Ueber die Glycin-carbonsäure

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

EQUILIBRIUM ULTRACENTRIFUGATION OF DILUTE SOLUTIONS

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Relationships between antibodies and experimental allergic encephalomyelitis. V. Antibodies and delayed hypersensitivity in production and prevention of experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Increases in serum lactate dehydrogenase in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Various Types of Acquired Resistance to Experimental ‘Allergic’ Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Encephalitogenic Factor in Experimental ‘Allergic’ Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Acquired resistance to experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Suppression of Experimental Allergic Encephalomyelitis by Cytotoxic Drugs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Identifiers

DOI

10.1002/EJI.1830010406

1 reference

24 December 2017

PubMed ID

5157960

1 reference

24 December 2017